These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21270242)

  • 1. Activation of peroxisome proliferator-activated receptor delta inhibits streptozotocin-induced diabetic nephropathy through anti-inflammatory mechanisms in mice.
    Matsushita Y; Ogawa D; Wada J; Yamamoto N; Shikata K; Sato C; Tachibana H; Toyota N; Makino H
    Diabetes; 2011 Mar; 60(3):960-8. PubMed ID: 21270242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of liver X receptor inhibits osteopontin and ameliorates diabetic nephropathy.
    Tachibana H; Ogawa D; Matsushita Y; Bruemmer D; Wada J; Teshigawara S; Eguchi J; Sato-Horiguchi C; Uchida HA; Shikata K; Makino H
    J Am Soc Nephrol; 2012 Nov; 23(11):1835-46. PubMed ID: 23085633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis.
    Takata Y; Liu J; Yin F; Collins AR; Lyon CJ; Lee CH; Atkins AR; Downes M; Barish GD; Evans RM; Hsueh WA; Tangirala RK
    Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4277-82. PubMed ID: 18337495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor δ downregulates the expression of the receptor for advanced glycation end products and pro-inflammatory cytokines in the kidney of streptozotocin-induced diabetic mice.
    Liang YJ; Chen SA; Jian JH
    Eur J Pharm Sci; 2011 May; 43(1-2):65-70. PubMed ID: 21458563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GW501516, a PPARδ agonist, ameliorates tubulointerstitial inflammation in proteinuric kidney disease via inhibition of TAK1-NFκB pathway in mice.
    Yang X; Kume S; Tanaka Y; Isshiki K; Araki S; Chin-Kanasaki M; Sugimoto T; Koya D; Haneda M; Sugaya T; Li D; Han P; Nishio Y; Kashiwagi A; Maegawa H; Uzu T
    PLoS One; 2011; 6(9):e25271. PubMed ID: 21966476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats.
    Collino M; Benetti E; Miglio G; Castiglia S; Rosa AC; Aragno M; Thiemermann C; Fantozzi R
    Free Radic Biol Med; 2011 Jan; 50(2):345-53. PubMed ID: 21047550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of retinoic acid in experimental diabetic nephropathy.
    Han SY; So GA; Jee YH; Han KH; Kang YS; Kim HK; Kang SW; Han DS; Han JY; Cha DR
    Immunol Cell Biol; 2004 Dec; 82(6):568-76. PubMed ID: 15550114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism.
    Lee MY; Choi R; Kim HM; Cho EJ; Kim BH; Choi YS; Naowaboot J; Lee EY; Yang YC; Shin JY; Shin YG; Chung CH
    Exp Mol Med; 2012 Oct; 44(10):578-85. PubMed ID: 22824914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of peroxisome proliferator-activated receptor-β/-δ (PPARβ/δ) prevents endothelial dysfunction in type 1 diabetic rats.
    Quintela AM; Jiménez R; Gómez-Guzmán M; Zarzuelo MJ; Galindo P; Sánchez M; Vargas F; Cogolludo A; Tamargo J; Pérez-Vizcaíno F; Duarte J
    Free Radic Biol Med; 2012 Aug; 53(4):730-41. PubMed ID: 22683600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telmisartan inhibits the proinflammatory effects of homocysteine on human endothelial cells through activation of the peroxisome proliferator-activated receptor-δ pathway.
    Xu S; Song H; Huang M; Wang K; Xu C; Xie L
    Int J Mol Med; 2014 Sep; 34(3):828-34. PubMed ID: 24994548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.
    Park CW; Kim HW; Ko SH; Chung HW; Lim SW; Yang CW; Chang YS; Sugawara A; Guan Y; Breyer MD
    Diabetes; 2006 Apr; 55(4):885-93. PubMed ID: 16567507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
    Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
    Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental study of leflunomide on renal protective effect and on inflammatory response of streptozotocin induced diabetic rats.
    Yu WM; Wang H; Ren XJ; Liu JP; Wang JY
    Nephrology (Carlton); 2012 May; 17(4):380-9. PubMed ID: 22243699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats.
    Tone A; Shikata K; Sasaki M; Ohga S; Yozai K; Nishishita S; Usui H; Nagase R; Ogawa D; Okada S; Shikata Y; Wada J; Makino H
    Diabetologia; 2005 Nov; 48(11):2402-11. PubMed ID: 16231067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase of peroxisome proliferator-activated receptor delta gene expression in the lungs of streptozotocin-induced diabetic rats.
    Huang CJ; Liu IM; Cheng JT
    Pulm Pharmacol Ther; 2007; 20(1):69-74. PubMed ID: 16406631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.
    Qin X; Xie X; Fan Y; Tian J; Guan Y; Wang X; Zhu Y; Wang N
    Hepatology; 2008 Aug; 48(2):432-41. PubMed ID: 18627005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role for osteopontin in diabetic nephropathy.
    Nicholas SB; Liu J; Kim J; Ren Y; Collins AR; Nguyen L; Hsueh WA
    Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.
    Chen HY; Huang XR; Wang W; Li JH; Heuchel RL; Chung AC; Lan HY
    Diabetes; 2011 Feb; 60(2):590-601. PubMed ID: 20980457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac peroxisome proliferator-activated receptor δ (PPARδ) as a new target for increased contractility without altering heart rate.
    Chen ZC; Lee KS; Chen LJ; Wang LY; Niu HS; Cheng JT
    PLoS One; 2013; 8(5):e64229. PubMed ID: 23724037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.